Literature DB >> 10501204

Toxicity of pyroglutaminated amyloid beta-peptides 3(pE)-40 and -42 is similar to that of A beta1-40 and -42.

T L Tekirian1, A Y Yang, C Glabe, J W Geddes.   

Abstract

An N-terminal truncated isoform of the amyloid beta-peptide (A beta) that begins with a pyroglutamate (pE) residue at position 3 [A beta3(pE)-42] is the predominant isoform found in senile plaques. Based upon previous in vitro studies regarding A beta N-terminal truncated isoforms, it has been hypothesized that A beta3(pE)-x isoforms may aggregate more rapidly and become more toxic than corresponding Abeta1-x peptides. However, the toxicity and aggregation properties of A beta3(pE)-42 and A beta3(pE)-40 have not previously been examined. After initial solubilization and 1-week preaggregation of each peptide at 37 degrees C and pH 7.4, the toxicity of 5-50 microM A beta3(pE)-42 was similar to that of A beta1-42. Moreover, the toxicity of A beta3(pE)-40 paralleled that induced by A beta1-40 in both 1 day in vitro (DIV) cortical and 7 DIV hippocampal cells. Circular dichroism spectra did not reveal major differences in secondary structure between aged A beta1-42, A beta3(pE)-42, A beta3(pE)-40, and A beta1-40 or freshly solubilized forms of these peptides. Overall, the data indicate that the loss of the two N-terminal amino acids and the cyclization of glutamate at position 3 do not alter the extracellular toxicity of A beta.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10501204     DOI: 10.1046/j.1471-4159.1999.0731584.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

1.  Amyloid-beta peptide Abetap3-42 affects early aggregation of full-length Abeta1-42.

Authors:  Hiromi M Sanders; Robert Lust; Jan K Teller
Journal:  Peptides       Date:  2009-02-11       Impact factor: 3.750

2.  Cortical pyroglutamate amyloid-β levels and cognitive decline in Alzheimer's disease.

Authors:  Violetta N Pivtoraiko; Eric E Abrahamson; Sue E Leurgans; Steven T DeKosky; Elliott J Mufson; Milos D Ikonomovic
Journal:  Neurobiol Aging       Date:  2014-06-24       Impact factor: 4.673

3.  In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.

Authors:  D M Walsh; D M Hartley; M M Condron; D J Selkoe; D B Teplow
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

4.  Amyloid-β Peptide Aβ3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons.

Authors:  Adam P Gunn; Bruce X Wong; Timothy Johanssen; James C Griffith; Colin L Masters; Ashley I Bush; Kevin J Barnham; James A Duce; Robert A Cherny
Journal:  J Biol Chem       Date:  2015-12-23       Impact factor: 5.157

Review 5.  Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease.

Authors:  Sadim Jawhar; Oliver Wirths; Thomas A Bayer
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

6.  Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric.

Authors:  Samir Kumar-Singh; Patrick Cras; Rong Wang; John M Kros; Johan van Swieten; Ursula Lübke; Chantal Ceuterick; Sally Serneels; Krist'l Vennekens; Jean-Pierre Timmermans; Eric Van Marck; Jean-Jacques Martin; Cornelia M van Duijn; Christine Van Broeckhoven
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Structures of Abeta-related peptide--monoclonal antibody complexes.

Authors:  Anna Gardberg; Lezlee Dice; Kathleen Pridgen; Jan Ko; Paul Patterson; Susan Ou; Ronald Wetzel; Chris Dealwis
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

8.  Isotope-edited FTIR reveals distinct aggregation and structural behaviors of unmodified and pyroglutamylated amyloid β peptides.

Authors:  Greg Goldblatt; Jason O Matos; Jeremy Gornto; Suren A Tatulian
Journal:  Phys Chem Chem Phys       Date:  2015-12-28       Impact factor: 3.676

9.  Discrete molecular dynamics study of oligomer formation by N-terminally truncated amyloid β-protein.

Authors:  Derya Meral; Brigita Urbanc
Journal:  J Mol Biol       Date:  2013-03-13       Impact factor: 5.469

10.  Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.

Authors:  Rebecca F Rosen; Yasushi Tomidokoro; Aaron S Farberg; Jeromy Dooyema; Brian Ciliax; Todd M Preuss; Thomas A Neubert; Jorge A Ghiso; Harry LeVine; Lary C Walker
Journal:  Neurobiol Aging       Date:  2016-05-02       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.